Jefferies reiterated their Underperform rating and $5 price target on Dendreon (NASDAQ: DNDN) following strong data from competitors at ASCO.
This article: 113 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE